Angelini Pharma Revenue, Growth & Competitor Profile

DBA ANGELINI PHARMACEUTICALS, INC.

Company Profile & Annual Report for Angelini Pharma

Access the complete profile.

Angelini Pharma Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325 Chemical Manufacturing 339112 Surgical & Medical Instrument Manufacturing
Address	230 Peachtree Street Nw Suite 1250 Atlanta, GA 30303

Note: Revenues for privately held companies are statistical evaluations.


Angelini Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Angelini Pharma's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Angelini Pharma is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Angelini Pharma Annual Revenue and Growth Rate

Angelini Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Angelini Pharma's revenues are gauged from an analysis of company filings.

Angelini Pharma's Income Statement (based on Industry Averages)

Angelini Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Angelini Pharma is developing and marketing. Angelini Pharma doesn't have any recent trademark applications, indicating Angelini Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALUVIS Sanitizing apparatus using ultraviolet light for sanitizing surfaces of electronic portable devices, cellular phones, portable phones, smart phones and electronic tablets, not for medical purposes	07/08/2014
AMUHEX Detergents for medical purposes	04/22/2014
PERACIDIN sterilant and disinfectant for use in reprocessed dialyzers	01/25/2011

See all trademarks and details in the Full Report.

Market Share of Angelini Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Angelini Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Angelini Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ANGELINI PHARMA	Atlanta, GA	100
GENEXA	Atlanta, GA	18
ALLIANCE COMMUNITY PHARMACY	Atlanta, GA	6
JBS	Atlanta, GA	5
TRIDENT MEDICAL GROUP	Atlanta, GA	2
CELTAXSYS	Atlanta, GA	1

Future Competition: Angelini Pharma's Fastest Growing Competitors

These companies are in the same general field as Angelini Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)